OBJECTIVE	The primary objective of the present study was to evaluate the effectiveness and adverse events of risedronate use in postmenopausal woman by measuring its effects on urinary crosslinked C-terminal telopeptides of type I collagen ( CTx ) , a biochemical marker of bone resorption .\